Development of an antimicrobial ink capable of coating medical surfaces for use in trauma reconstruction

  1. Home
  2. keyboard_arrow_right
  3. Reconstruction
  4. keyboard_arrow_right
  5. Development of an antimicrobial ink capable of coating medical surfaces for use in trauma reconstruction
Milestone n:0%
What does each milestone mean?

    1 = Clinical need
    2 = Idea
    3 = Proof of concept
    4 = Proof of feasibility
    5 = Proof of value
    6 = Initial clinical trials
    7 = Validation of solution
    8 = Approval and launch
    9 = Clinical use
    10 = Standard of care


We aim to modify the way we functionalise surfaces by developing an antimicrobial ink based on antimicrobial peptides and smart materials such as the human elastin-like polypeptide (HELP) initially synthesised by Dr Antonella Bandiera at the University of Trieste. This polypeptide will have the capacity to be intrinsically antimicrobial by conjugating in tagged positions, novel antimicrobial peptides that mimic the structure of human defensins or by incorporating in the structure the antimicrobial peptide sequences by applying molecular biology. The second route will lead to a new modified HELP.

Lay Summary

An antimicrobial ink will be developed based on previously uncovered antimicrobial peptides embedded or fused with the elastin-like human polypeptide. The ink will have antimicrobial behaviour that will address infection problems as well as antimicrobial resistance in orthopaedics and potentially in other medical areas. The ink will be able to be 3D printed on any medical surface (metal, polymer, ceramic).


Building on a previous MRC CiC-funded project, we have the opportunity to accelerate the development of antimicrobial implants for surgical reconstruction after trauma. Unfortunately, bacterial colonisation is very common after implantation of prosthetics or devices following injury as the fragility of traumatised tissue, coupled with the immunocompromised state of trauma survivors, creates a very favourable environment for infection. Implant infection can undo months of painstaking reconstruction, resulting not only in significant costs for the NHS but also a massive psychological downturn for the patient.

Our team previously created antimicrobial peptides capable of disrupting the bacterial cell membrane on contact. We showed that the peptides could be attached to the surface of titanium following chemical and thermal treatments of the surface and attachment of the peptides using titanium binders. This method although successful, it requires conjugation of the peptides with the binders that can interfere with the antimicrobial activity.


Design and production of a biomimetic elastin-like polypeptide scaffold with antibacterial bioactive domains. The polypeptide can be designed to be easily modified by the insertion of a bioactive domain in the C-terminal region. A new macromolecule that will be the result of the fusion between the elastin-like biopolymer and an antibacterial peptide sequence will be produced and fully characterised.

Incorporation of synthetic antibacterial peptides in the biomimetic elastin-like scaffold by an enzymatic route using transglutaminase. The antibacterial peptides will be embedded within the matrix that will be cross-linked by the use of a transglutaminase.

Release of the peptides realized by two ways:

  • Release triggered by a thermo-responsive behaviour.
  • Release triggered by aproteolytic or elastolytic activity.

The antimicrobial ink will be placed by 3D printing on modified (either by plasma treatment or chemical treatment) titanium surfaces and polymers.

Research Team

Miss HaniehIjakipour
Mr Marc Bruggeman
Dr Antonella Bandiera

Related Projects